Immunome Inc.·4

Aug 13, 5:40 PM ET

Lechleider Robert 4

4 · Immunome Inc. · Filed Aug 13, 2024

Insider Transaction Report

Form 4
Period: 2024-08-09
Lechleider Robert
Chief Medical Officer
Transactions
  • Award

    Stock option (right to buy)

    2024-08-09+200,000200,000 total
    Exercise: $12.92Exp: 2034-08-08Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the options vest on August 9, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.

Documents

1 file
  • 4
    form4-08132024_090844.xmlPrimary